Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Arnold

Showing results (131-140 of 356) with videos related to

Pageof 36
Sort By:
Connective Tissue Research|November 8, 2013
Testing the anti-fibrotic potential of the single-chain Fv antibody against the α2 C-terminal telopeptide of collagen IJolanta Fertala, James Kostas, Cheryl Hou, et al.
Circulation. Cardiovascular Quality and Outcomes|December 25, 2009
Economic impact of angina after an acute coronary syndrome: insights from the MERLIN-TIMI 36 trialSuzanne V Arnold, David A Morrow, Yang Lei, et al.
American Heart Journal|May 16, 2016
Patient and physician discordance in reporting symptoms of angina among stable coronary artery disease patients: Insights from the Angina Prevalence and Provider Evaluation of Angina Relief (APPEAR) studyAli Shafiq, Suzanne V Arnold, Kensey Gosch, et al.
Journal of Andrology|January 6, 1999
Sperm motility enhancement by nitric oxide produced by the oocytes of fathead minnows, Pimephelas promelasM M Creech, E V Arnold, B Boyle, et al.
Circulation|December 23, 2009
Cost-effectiveness of prasugrel versus clopidogrel in patients with acute coronary syndromes and planned percutaneous coronary intervention: results from the trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with Prasugrel-Thrombolysis in Myocardial Infarction TRITON-TIMI 38Elizabeth M Mahoney, Kaijun Wang, Suzanne V Arnold, et al.
Circulation. Cardiovascular Quality and Outcomes|August 27, 2015
Association of Smoking Status With Angina and Health-Related Quality of Life After Acute Myocardial InfarctionDonna M Buchanan, Suzanne V Arnold, Kensey L Gosch, et al.
JACC. Heart Failure|May 4, 2023
Beta-Blocker Use and Heart Failure Outcomes in Mildly Reduced and Preserved Ejection FractionSuzanne V Arnold, Daniel N Silverman, Kensey Gosch, et al.
Circulation|February 6, 2014
Patterns of statin initiation, intensification, and maximization among patients hospitalized with an acute myocardial infarctionSuzanne V Arnold, Mikhail Kosiborod, Fengming Tang, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|March 18, 2025
Temporal Patterns in Blood Pressure Management Before and After Recent Clinical Trials and Guideline RecommendationsEric J Brandt, Craig J Beavers, Zhuxuan Fu, et al.
Journal of the American College of Cardiology|October 28, 2023
Health Status After Transcatheter Tricuspid-Valve Repair in Patients With Severe Tricuspid RegurgitationSuzanne V Arnold, Scott Goates, Paul Sorajja, et al.
Pageof 36

Showing results (131-140 of 356) with videos related to

Sort By:
Pageof 36
Connective Tissue Research|November 8, 2013
Testing the anti-fibrotic potential of the single-chain Fv antibody against the α2 C-terminal telopeptide of collagen IJolanta Fertala, James Kostas, Cheryl Hou, et al.
Circulation. Cardiovascular Quality and Outcomes|December 25, 2009
Economic impact of angina after an acute coronary syndrome: insights from the MERLIN-TIMI 36 trialSuzanne V Arnold, David A Morrow, Yang Lei, et al.
American Heart Journal|May 16, 2016
Patient and physician discordance in reporting symptoms of angina among stable coronary artery disease patients: Insights from the Angina Prevalence and Provider Evaluation of Angina Relief (APPEAR) studyAli Shafiq, Suzanne V Arnold, Kensey Gosch, et al.
Journal of Andrology|January 6, 1999
Sperm motility enhancement by nitric oxide produced by the oocytes of fathead minnows, Pimephelas promelasM M Creech, E V Arnold, B Boyle, et al.
Circulation|December 23, 2009
Cost-effectiveness of prasugrel versus clopidogrel in patients with acute coronary syndromes and planned percutaneous coronary intervention: results from the trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with Prasugrel-Thrombolysis in Myocardial Infarction TRITON-TIMI 38Elizabeth M Mahoney, Kaijun Wang, Suzanne V Arnold, et al.
Circulation. Cardiovascular Quality and Outcomes|August 27, 2015
Association of Smoking Status With Angina and Health-Related Quality of Life After Acute Myocardial InfarctionDonna M Buchanan, Suzanne V Arnold, Kensey L Gosch, et al.
JACC. Heart Failure|May 4, 2023
Beta-Blocker Use and Heart Failure Outcomes in Mildly Reduced and Preserved Ejection FractionSuzanne V Arnold, Daniel N Silverman, Kensey Gosch, et al.
Circulation|February 6, 2014
Patterns of statin initiation, intensification, and maximization among patients hospitalized with an acute myocardial infarctionSuzanne V Arnold, Mikhail Kosiborod, Fengming Tang, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|March 18, 2025
Temporal Patterns in Blood Pressure Management Before and After Recent Clinical Trials and Guideline RecommendationsEric J Brandt, Craig J Beavers, Zhuxuan Fu, et al.
Journal of the American College of Cardiology|October 28, 2023
Health Status After Transcatheter Tricuspid-Valve Repair in Patients With Severe Tricuspid RegurgitationSuzanne V Arnold, Scott Goates, Paul Sorajja, et al.
Pageof 36